REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/23/2026
Back to search
Official data from USPTO
RETRONOSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/24/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
11/07/2019
Registration date
02/23/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/23/2021
Last transaction
02/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
SAINT-ETIENNE, FR
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
L. F. (pessoa física)
U. T. (pessoa física)
Representatives
Janet G Ricciuti JANET GILBERT RICCIUTI
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsmedicines and chemical preparations for medical use for the treatment of immune system related diseases and disordersfor treating or preventing of respiratory diseases and disordersof infectious diseasesof inflammationof upper airways cancer diseasesof radioactive contaminationof biohazard contaminationof paincentral nervous system diseasescardiovascular diseasesmetabolic diseasesof asthmaof allergies; vaccines; Medicines for medical use for the treatment of immune system related diseases and disordersfor treating or preventing of respiratory diseases and disordersof infectious diseasesof inflammationof upper airways cancer diseasesof radioactive contaminationof biohazard contaminationof paincentral nervous system diseasescardiovascular diseasesmetabolic diseasesof asthmaof allergies; vaccines for humans; Chemical preparations for medical usefor the treatment of immune system related diseases and disordersfor treating or preventing of respiratory diseases and disordersof infectious diseasesof inflammationof upper airways cancer diseasesof radioactive contaminationof biohazard contaminationof paincentral nervous system diseasescardiovascular diseasesmetabolic diseasesof asthmaof allergies; vaccines; Chemical preparations for pharmaceutical usefor the treatment of immune system related diseases and disordersfor treating or preventing of respiratory diseases and disordersof infectious diseasesof inflammationof upper airways cancer diseasesof radioactive contaminationof biohazard contaminationof paincentral nervous system diseasescardiovascular diseasesmetabolic diseasesof asthmaof allergies; vaccines
Class 10
Medical apparatus and instrumentssurgical apparatus and instruments for use in general and minimally invasive surgery; Apparatus for distributiondosage and administration of medical productsaerosol dispensers and inhalersdry powder inhalersnebulizerspressurized metered dose inhalerssoft mist inhalers all for medical purposes; Apparatus for distributiondosage and administration of pharmaceutical productsaerosol dispensers and inhalersdry powder inhalersnebulizerspressurized metered dose inhalerssoft mist inhalers all for medical use; Apparatus in the nature of inhalers and nebulizers for administering aerosols all for medical use; Apparatus actuated by nasal expiratory phase for administering sprays for medical usenasal aspirators; Inhalers and apparatus actuated by nasal expiratory phasenasal aspirators for administering medicines for nasalrhinologicallaryngeal and oral cavity effect
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/24/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/26/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
05/26/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2020
PUBO
PUBLISHED FOR OPPOSITION
12/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/18/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2020
ALIE
ASSIGNED TO LIE
10/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2020
RFNT
REFUSAL PROCESSED BY IB
03/21/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2020
RFRR
REFUSAL PROCESSED BY MPU
03/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/11/2020
DOCK
ASSIGNED TO EXAMINER
02/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/26/2019
Continuous trademark protection
Get notified about every new filing that threatens RETRONOSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.